Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Musk defends his ketamine use as beneficial for investors in new video

Published 03/18/2024, 12:09 PM
Updated 03/18/2024, 12:19 PM
© Reuters. FILE PHOTO: Elon Musk attends the premiere of ''Lola'' held at the Regency Bruin Theatre in Los Angeles, California, U.S.,  February 3, 2024. REUTERS/Aude Guerrucci/File Photo

By Sheila Dang

(Reuters) - CEO Elon Musk said his ketamine prescription was beneficial for Tesla (NASDAQ:TSLA)'s investors in a video interview with former CNN anchor Don Lemon posted online on Monday.

Musk said the drug helps him manage a "negative chemical state" similar to depression in the interview conducted this month that also touched on politics, content moderation on X and Tesla. 

"From the standpoint of Wall Street, what matters is execution," said Musk, who runs the automaker, the rocket company SpaceX and the social media platform X. Musk argued Tesla was worth as much as the rest of the car industry combined.

"For investors, if there's something I'm taking, I should keep taking it."

A Wall Street Journal investigation published in January said Musk had used drugs including LSD, cocaine, ecstasy and psychedelic mushrooms, worrying executives and board members at his companies. 

The report raised concerns that illegal drug use would likely be a violation of federal policies that could jeopardize SpaceX's government contracts.

The Journal, citing people familiar with the matter, reported that one Tesla director grew so frustrated with Musk's behavior that she did not stand for re-election to the board in 2019.

Musk responded to the Journal report on X in January, saying that he agreed to three years of random drug testing at the request of the National Aeronautics and Space Administration, which partners with SpaceX. "Not even trace quantities were found of any drugs or alcohol," Musk said. 

Musk told Lemon that he had a doctor's prescription for ketamine. The billionaire estimated he took "a small amount every other week."

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

His comments were in response to Lemon asking what Musk's ketamine prescription was intended for, and if he ever worried "that this may get in the way of your government contracts and clearances and Wall Street as well."

Lemon posted the interview on YouTube and X, after he said last week that Musk canceled an exclusive partnership that "The Don Lemon Show" had with X.

Lemon was set to have three 30-minute episodes per week on X. "His approach was basically just CNN, but on social media, which doesn't work," Musk posted on X.

Musk did not respond to a request for comment from Reuters.

Latest comments

More fake news. Reuters is DESPERATE to paint a negative picture regardless if it's factual or not.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.